Next-generation sequencing produces enormous amounts of data, and turning it into clinical answers requires robust bioinformatics. For molecular labs, NGS data analysis covers the whole chain: quality control, alignment, variant calling, CNV detection, annotation and interpretation, all within validated and compliant workflows.
In this section, we gather our articles on NGS data analysis for molecular labs: practical guides on building and scaling pipelines, insights on accuracy and turnaround time, regulatory topics such as IVDR, and stories from labs that use SeqOne to streamline their genomic workflows.

Meet UP²-SV: a dedicated AI pathogenicity classifier for structural variants, trained on 65,000+ ClinVar SVs and validated on a clinical cohort with 97.6% sensitivity. AI-powered prioritization now spans the full variant spectrum.
A Spanish hospital ended a patient's 30-year diagnostic odyssey by combining Agilent's advanced exome sequencing with SeqOne's AI platform, uncovering a rare DMD gene duplication that had eluded detection for decades.

Genekor Medical, a Romanian diagnostics lab, uses SeqOne's platform to make HRD testing a routine clinical workflow. Using shallow whole genome sequencing and automated FASTQ-to-GIS analysis, they've cut complexity and costs, proving that reliable precision oncology testing is achievable for regional labs beyond major European hubs.